{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:27:53Z","timestamp":1760142473241,"version":"build-2065373602"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.annfar.2011.03.016","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T09:22:39Z","timestamp":1308993759000},"page":"501-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anesth\u00e9sie du patient infect\u00e9 par le VIH"],"prefix":"10.1016","volume":"30","author":[{"given":"L.","family":"Bornard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Blay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-M.","family":"Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Raucoules-Aim\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Carles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annfar.2011.03.016_bib0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0750-7658(99)80125-7","article-title":"Anesth\u00e9sie du patient VIH positif ou atteint du sida","volume":"18","author":"Balabaud-Pichon","year":"1999","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.annfar.2011.03.016_bib0010","first-page":"398","article-title":"HIV infection in Europe","volume":"46","author":"Nardone","year":"2007","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.annfar.2011.03.016_bib0015","first-page":"386","article-title":"HIV and AIDS surveillance in France, 2006","volume":"46","author":"Pillonel","year":"2007","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.annfar.2011.03.016_bib0020","first-page":"1","article-title":"Surveillance of HIV screening and HIV\/AIDS diagnosis France, 2008","volume":"2","author":"Cazein","year":"2009","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.annfar.2011.03.016_bib0025","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s001010070015","article-title":"Aids and anesthesia","volume":"49","author":"Eichler","year":"2000","journal-title":"Anaesthesist"},{"key":"10.1016\/j.annfar.2011.03.016_bib0030","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00268-009-9969-6","article-title":"Human immunodeficiency disease: how should it affect surgical decision making?","volume":"33","author":"Madiba","year":"2009","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.annfar.2011.03.016_bib0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAD.0b013e3283324283","article-title":"The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals","volume":"24","author":"Ray","year":"2010","journal-title":"Aids"},{"key":"10.1016\/j.annfar.2011.03.016_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJM199807023390107","article-title":"Acute human immunodeficiency virus type\u00a01\u00a0infection","volume":"339","author":"Kahn","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0045","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/QAD.0b013e32832b44c8","article-title":"Prevalence and comparative characteristics of long-term non progressors and HIV controller patients in the French Hospital Database on HIV","volume":"23","author":"Grabar","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.annfar.2011.03.016_bib0050","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1378\/chest.08-0364","article-title":"Changing global epidemiology of pulmonary manifestations of HIV\/AIDS","volume":"134","author":"Hull","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.annfar.2011.03.016_bib0055","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1378\/chest.111.5.1193","article-title":"Alveolar damage in AIDS-related Pneumocystis carinii pneumonia","volume":"111","author":"Benfield","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.annfar.2011.03.016_bib0060","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(06)68383-9","article-title":"Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment","volume":"367","author":"Corbett","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2011.03.016_bib0065","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/503903","article-title":"Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy","volume":"42","author":"Robertson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annfar.2011.03.016_bib0070","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1210\/jc.2005-0036","article-title":"Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases","volume":"90","author":"Samaras","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.annfar.2011.03.016_bib0075","doi-asserted-by":"crossref","first-page":"769","DOI":"10.7326\/0003-4819-121-10-199411150-00008","article-title":"Neurologic manifestations of HIV infection","volume":"121","author":"Simpson","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11065-009-9094-1","article-title":"HIV infection and the central nervous system: a primer","volume":"19","author":"Ellis","year":"2009","journal-title":"Neuropsychol Rev"},{"issue":"Suppl. 3","key":"10.1016\/j.annfar.2011.03.016_bib0085","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1097\/01.aids.0000192079.49185.f9","article-title":"Effects of hepatic function and hepatitis\u00a0C virus on the nervous system assessment of advanced-stage HIV-infected individuals","volume":"19","author":"Morgello","year":"2005","journal-title":"Aids"},{"key":"10.1016\/j.annfar.2011.03.016_bib0090","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/426076","article-title":"Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort","volume":"40","author":"Lichtenstein","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annfar.2011.03.016_bib0095","doi-asserted-by":"crossref","first-page":"e14433","DOI":"10.1371\/journal.pone.0014433","article-title":"Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials","volume":"5","author":"Phillips","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.annfar.2011.03.016_bib0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.107.189622","article-title":"State of the science conference: initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV\/AIDS: executive summary","volume":"118","author":"Grinspoon","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.annfar.2011.03.016_bib0110","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0002-9149(93)90913-W","article-title":"Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection","volume":"71","author":"Herskowitz","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.annfar.2011.03.016_bib0120","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.amjmed.2003.10.011","article-title":"Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans","volume":"116","author":"Fultz","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/157340308785160589","article-title":"The relationship between HIV infection and cardiovascular disease","volume":"4","author":"Dau","year":"2008","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.annfar.2011.03.016_bib0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/apc.2008.0010","article-title":"Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era","volume":"22","author":"Crum-Cianflone","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.annfar.2011.03.016_bib0135","first-page":"18","article-title":"Gastro-intestinal infections in immunocompromised hosts","volume":"22","author":"Thom","year":"2006","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.annfar.2011.03.016_bib0140","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","article-title":"Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients","volume":"24","author":"Mocroft","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.annfar.2011.03.016_bib0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2011.03.016_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":"Adherence to protease inhibitor therapy and outcomes in patients with HIV infection","volume":"133","author":"Paterson","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/427192","article-title":"Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy","volume":"191","author":"Harrigan","year":"2005","journal-title":"J Infect Dis"},{"unstructured":"Prise en charge m\u00e9dicale des personnes infect\u00e9es par le VIH. Rapport 2010 \u2013 sous la direction de P.\u00a0Yeni. Vienne: \u00c9dition sp\u00e9ciale AIDS 2010, www.sante.gouv.fr; 2010. 418\u00a0p.","key":"10.1016\/j.annfar.2011.03.016_bib0160"},{"key":"10.1016\/j.annfar.2011.03.016_bib0165","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0170","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1086\/501458","article-title":"Marked intra-individual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring","volume":"42","author":"Nettles","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annfar.2011.03.016_bib0175","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1086\/491738","article-title":"Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4\u00a0cell counts more than 200\u00a0cells per millimeter cube","volume":"192","author":"Toulson","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annfar.2011.03.016_bib0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJMra050836","article-title":"Intensive care of patients with HIV infection","volume":"355","author":"Huang","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0185","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200306130-00007","article-title":"Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy","volume":"17","author":"Nolan","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.annfar.2011.03.016_bib0190","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.296.7.844","article-title":"Metabolic and skeletal complications of HIV infection: the price of success","volume":"296","author":"Morse","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2011.03.016_bib0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00003088-200241010-00004","article-title":"Drug interactions with patient-controlled analgesia","volume":"41","author":"Lotsch","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. 4","key":"10.1016\/j.annfar.2011.03.016_bib0200","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1086\/508186","article-title":"Pharmacokinetic interactions between buprenorphine and antiretroviral medications","volume":"43","author":"Bruce","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annfar.2011.03.016_bib0205","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1345\/aph.1A447","article-title":"Interactions between recreational drugs and antiretroviral agents","volume":"36","author":"Antoniou","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"Suppl. 1","key":"10.1016\/j.annfar.2011.03.016_bib0210","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00126334-200309011-00013","article-title":"Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy","volume":"34","author":"Montaner","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.annfar.2011.03.016_bib0215","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1136\/bmj.332.7556.1489","article-title":"Antiretroviral treatment of HIV infected adults","volume":"332","author":"Deeks","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.annfar.2011.03.016_bib0220","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2165\/00003088-200241140-00004","article-title":"Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection","volume":"41","author":"Fichtenbaum","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.annfar.2011.03.016_bib0225","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.annfar.2011.03.016_bib0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0003-9861(90)90442-2","article-title":"Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3\u2019-azido-3\u2019-deoxythymidine: characterization of the enzyme in human and rat liver microsomes","volume":"281","author":"Haumont","year":"1990","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.annfar.2011.03.016_bib0235","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0090-9556(25)08724-0","article-title":"3\u2019-azido-3\u2019-deoxythymidine drug interactions. Screening for inhibitors in human liver microsomes","volume":"20","author":"Rajaonarison","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.annfar.2011.03.016_bib0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2125.1991.tb05607.x","article-title":"The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes","volume":"32","author":"Sim","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.annfar.2011.03.016_bib0245","first-page":"88","article-title":"Drug-drug interactions that matter","volume":"14","author":"Back","year":"2006","journal-title":"Top HIV Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0250","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jama.300.5.555","article-title":"Antiretroviral treatment of adult HIV infection: 2008\u00a0recommendations of the International AIDS Society-USA panel","volume":"300","author":"Hammer","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2011.03.016_bib0255","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.annfar.2011.03.016_bib0260","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2337\/diacare.28.1.132","article-title":"Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors","volume":"28","author":"Jerico","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.annfar.2011.03.016_bib0265","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1592\/phco.2005.25.10.1348","article-title":"Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors","volume":"25","author":"Devlin","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.annfar.2011.03.016_bib0270","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00115550-200607000-00008","article-title":"Regional anesthesia in the immunocompromised patient","volume":"31","author":"Horlocker","year":"2006","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0275","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1213\/01.ANE.0000097193.91244.50","article-title":"Human immunodeficiency virus: anesthetic and obstetric considerations","volume":"98","author":"Evron","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1016\/j.annfar.2011.03.016_bib0280","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0952-8180(03)00029-1","article-title":"Human immunodeficiency virus in the parturient","volume":"15","author":"Kuczkowski","year":"2003","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.annfar.2011.03.016_bib0285","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.annepidem.2009.08.006","article-title":"Management practices and risk of occupational blood exposure in US paramedics: non-intact skin exposure","volume":"19","author":"Leiss","year":"2009","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annfar.2011.03.016_bib0290","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jhin.2009.03.016","article-title":"Occupational transmission of bloodborne diseases to healthcare workers in developing countries: meeting the challenges","volume":"72","author":"Lee","year":"2009","journal-title":"J Hosp Infect"},{"issue":"1","key":"10.1016\/j.annfar.2011.03.016_bib0355","first-page":"CD002835","article-title":"Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure","author":"Young","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annfar.2011.03.016_bib0300","first-page":"225","article-title":"\u00c9valuation nationale de la prise en charge th\u00e9rapeutique des expositions au VIH\u00a0: impact des recommandations d\u2019avril\u00a02003","volume":"48","author":"Lot","year":"2004","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.annfar.2011.03.016_bib0305","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1001\/jama.285.12.1592","article-title":"Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial","volume":"285","author":"Collier","year":"2001","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"10.1016\/j.annfar.2011.03.016_bib0310","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1186\/cc2847","article-title":"Infectious and immunologic consequences of blood transfusion","volume":"8","author":"Dellinger","year":"2004","journal-title":"Crit Care"},{"issue":"Suppl. 2","key":"10.1016\/j.annfar.2011.03.016_bib0315","first-page":"1S","article-title":"Emerging infectious disease agents and their potential threat to transfusion safety","volume":"49","author":"Stramer","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.annfar.2011.03.016_bib0320","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.tp.0000282873.24648.5b","article-title":"Outcomes after orthotopic liver transplantation in 15\u00a0HIV-infected patients","volume":"84","author":"Schreibman","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.annfar.2011.03.016_bib0325","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1378\/chest.125.5.1800","article-title":"Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy","volume":"125","author":"Narasimhan","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.annfar.2011.03.016_bib0330","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00134-004-2158-z","article-title":"Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era","volume":"30","author":"Vincent","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ije\/dyh307","article-title":"Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS","volume":"34","author":"Lewden","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.annfar.2011.03.016_bib0340","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.CCM.0000194539.50905.81","article-title":"Current issues in critical care of the human immunodeficiency virus-infected patient","volume":"34","author":"Morris","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annfar.2011.03.016_bib0345","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/CCM.0b013e31819da8c7","article-title":"Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit","volume":"37","author":"Croda","year":"2009","journal-title":"Crit Care Med"}],"container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075076581100147X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075076581100147X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:13:09Z","timestamp":1760091189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075076581100147X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S075076581100147X"],"URL":"https:\/\/doi.org\/10.1016\/j.annfar.2011.03.016","relation":{},"ISSN":["0750-7658"],"issn-type":[{"type":"print","value":"0750-7658"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anesth\u00e9sie du patient infect\u00e9 par le VIH","name":"articletitle","label":"Article Title"},{"value":"Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annfar.2011.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}